Your browser doesn't support javascript.
loading
Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
Pachev, Atanas; Raynaud, Lucas; Paulatto, Luisa; Dioguardi Burgio, Marco; Roche, Vincent; Garcia Alba, Carmela; Sibert, Annie; Lagadec, Matthieu; Kavafyan-Lasserre, Juliette; Paugam-Burtz, Catherine; Vilgrain, Valérie; Ronot, Maxime.
Afiliação
  • Pachev A; Department of Radiology, APHP.Nord, Hôpital Beaujon, Clichy, Hauts-de-Seine, France.
  • Raynaud L; Department of Radiology, APHP.Nord, Hôpital Beaujon, Clichy, Hauts-de-Seine, France.
  • Paulatto L; Department of Radiology, APHP.Nord, Hôpital Beaujon, Clichy, Hauts-de-Seine, France.
  • Dioguardi Burgio M; Department of Radiology, APHP.Nord, Hôpital Beaujon, Clichy, Hauts-de-Seine, France.
  • Roche V; INSERM U1149, CRI, Paris, France.
  • Garcia Alba C; Department of Radiology, APHP.Nord, Hôpital Beaujon, Clichy, Hauts-de-Seine, France.
  • Sibert A; Université de Paris, Paris, France.
  • Lagadec M; Department of Radiology, APHP.Nord, Hôpital Beaujon, Clichy, Hauts-de-Seine, France.
  • Kavafyan-Lasserre J; Department of Radiology, APHP.Nord, Hôpital Beaujon, Clichy, Hauts-de-Seine, France.
  • Paugam-Burtz C; Department of Radiology, APHP.Nord, Hôpital Beaujon, Clichy, Hauts-de-Seine, France.
  • Vilgrain V; Department of Anaesthesiology, APHP.Nord, Hôpital Beaujon, Clichy, Hauts-de-Seine, France.
  • Ronot M; Université de Paris, Paris, France.
Eur Radiol ; 31(5): 3267-3275, 2021 May.
Article em En | MEDLINE | ID: mdl-33123789
OBJECTIVES: To prospectively assess the frequency of severe abdominal pain during and after transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) using the visual analog scale (VAS), and to identify predictive factors. METHODS: Ninety-eight TACE performed in 80 patients (mean 65 ± 12 years old, 60 men) were consecutively and prospectively included. Abdominal pain was considered severe if the VAS ≥ 30/100 after treatment administration, or if opioid analgesic (grades 2-3) intake was required during hospitalization. Patient and tumor characteristics as well as technical factors associated with severe pain were identified by binary logistic regression. RESULTS: The criterion for severe pain was met in 41/98 (42%) of procedures (peri-procedural pain 30/98 [31%] and opioid consumption during hospitalization 24/98 [25%]). Multivariate analysis identified age (odds ratio [OR] = 0.943 (95% confidence interval 0.895-0.994), p = 0.029), cirrhosis (OR = 0.284 (0.083-0.971), p = 0.045), and alcoholic liver disease (OR = 0.081 (0.010-0.659), p = 0.019) as negative predictive factors of severe abdominal pain. Severe abdominal pain occurred in or after 1/13 (8%), 8/34 (24%), 22/41 (54%), and 10/10 (100%) TACE sessions when none, one, two, and three of the protective factors were absent, respectively (p < 0.001). The area under the ROC curve of the combination of factors for the prediction of severe abdominal pain was 0.779 (CI 0.687-0.871). CONCLUSION: Severe abdominal pain was frequent during and after TACE revealing a clinically relevant and underestimated problem. A predictive model based on three readily available clinical variables suggests that young patients without alcoholic liver disease or cirrhosis could benefit from reinforced analgesia. KEY POINTS: • Severe abdominal pain occurs in 43% of TACE for HCC. • Younger age, absence of cirrhosis, and absence of alcoholic liver disease were identified as independent predictive factors of severe abdominal pain. • A simple combination of the three abovementioned features helped predict the occurrence of severe abdominal pain.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article